Search research articles
Contact Us
Filters
Showing results (21-30 of 37) with videos related to
Page
of 4
Sort By:
Nature Medicine
|
December 11, 2007
Purging metastases in lymphoid organs using a combination of antigen-nonspecific adoptive T cell therapy, oncolytic virotherapy and immunotherapy
Jian Qiao, Timothy Kottke, Candice Willmon, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
October 2, 2008
Use of biological therapy to enhance both virotherapy and adoptive T-cell therapy for cancer
Timothy Kottke, Rosa M Diaz, Karen Kaluza, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
April 16, 2009
A phase I/II clinical trial in localized prostate cancer of an adenovirus expressing nitroreductase with CB1954 [correction of CB1984]
Prashant Patel, J Graham Young, Vivien Mautner, et al.
Investigational New Drugs
|
January 19, 2013
Phase II study to assess the efficacy, safety and tolerability of the mitotic spindle kinesin inhibitor AZD4877 in patients with recurrent advanced urothelial cancer
Robert Jones, Jacqueline Vuky, Tony Elliott, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 13, 2024
Improved Disease-Free Survival With Adjuvant Chemotherapy After Nephroureterectomy for Upper Tract Urothelial Cancer: Final Results of the POUT Trial
Alison Jane Birtle, Robert Jones, John Chester, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 31, 2016
Phase III, Double-Blind, Randomized Trial That Compared Maintenance Lapatinib Versus Placebo After First-Line Chemotherapy in Patients With Human Epidermal Growth Factor Receptor 1/2-Positive Metastatic Bladder Cancer
Thomas Powles, Robert A Huddart, Tony Elliott, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 10, 2012
Phase I/II trial of carboplatin and paclitaxel chemotherapy in combination with intravenous oncolytic reovirus in patients with advanced malignancies
Eleni M Karapanagiotou, Victoria Roulstone, Katie Twigger, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 13, 2017
COAST (Cisplatin ototoxicity attenuated by aspirin trial): A phase II double-blind, randomised controlled trial to establish if aspirin reduces cisplatin induced hearing-loss
Simon J Crabb, Karen Martin, Julia Abab, et al.
Lancet (London, England)
|
March 9, 2020
Adjuvant chemotherapy in upper tract urothelial carcinoma (the POUT trial): a phase 3, open-label, randomised controlled trial
Alison Birtle, Mark Johnson, John Chester, et al.
Therapeutic Advances in Medical Oncology
|
September 9, 2021
Specialist palliative and end-of-life care for patients with cancer and SARS-CoV-2 infection: a European perspective
Gehan Soosaipillai, Anjui Wu, Gino M Dettorre, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 37) with videos related to
Sort By:
Page
of 4
Nature Medicine
|
December 11, 2007
Purging metastases in lymphoid organs using a combination of antigen-nonspecific adoptive T cell therapy, oncolytic virotherapy and immunotherapy
Jian Qiao, Timothy Kottke, Candice Willmon, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
October 2, 2008
Use of biological therapy to enhance both virotherapy and adoptive T-cell therapy for cancer
Timothy Kottke, Rosa M Diaz, Karen Kaluza, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
April 16, 2009
A phase I/II clinical trial in localized prostate cancer of an adenovirus expressing nitroreductase with CB1954 [correction of CB1984]
Prashant Patel, J Graham Young, Vivien Mautner, et al.
Investigational New Drugs
|
January 19, 2013
Phase II study to assess the efficacy, safety and tolerability of the mitotic spindle kinesin inhibitor AZD4877 in patients with recurrent advanced urothelial cancer
Robert Jones, Jacqueline Vuky, Tony Elliott, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 13, 2024
Improved Disease-Free Survival With Adjuvant Chemotherapy After Nephroureterectomy for Upper Tract Urothelial Cancer: Final Results of the POUT Trial
Alison Jane Birtle, Robert Jones, John Chester, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 31, 2016
Phase III, Double-Blind, Randomized Trial That Compared Maintenance Lapatinib Versus Placebo After First-Line Chemotherapy in Patients With Human Epidermal Growth Factor Receptor 1/2-Positive Metastatic Bladder Cancer
Thomas Powles, Robert A Huddart, Tony Elliott, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 10, 2012
Phase I/II trial of carboplatin and paclitaxel chemotherapy in combination with intravenous oncolytic reovirus in patients with advanced malignancies
Eleni M Karapanagiotou, Victoria Roulstone, Katie Twigger, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 13, 2017
COAST (Cisplatin ototoxicity attenuated by aspirin trial): A phase II double-blind, randomised controlled trial to establish if aspirin reduces cisplatin induced hearing-loss
Simon J Crabb, Karen Martin, Julia Abab, et al.
Lancet (London, England)
|
March 9, 2020
Adjuvant chemotherapy in upper tract urothelial carcinoma (the POUT trial): a phase 3, open-label, randomised controlled trial
Alison Birtle, Mark Johnson, John Chester, et al.
Therapeutic Advances in Medical Oncology
|
September 9, 2021
Specialist palliative and end-of-life care for patients with cancer and SARS-CoV-2 infection: a European perspective
Gehan Soosaipillai, Anjui Wu, Gino M Dettorre, et al.
Page
of 4